Educational level and first-time PSA testing in general practice

References

• Mukai TO, Bro F, Pedersen KV, et al. [Use of prostate-specific antigen testing]. Ugeskr Laeger. 2010;172(9):696–700. Danish.
   PubMedGoogle Scholar
• Nordstrom T, Aly M, Clements MS, et al. Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011. Eur Urol. 2013;63(3):419–425.
   PubMed Web of Science ®Google Scholar
• Zhou CK, Check DP, Lortet-Tieulent J, et al. Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. Int J Cancer. 2016;138(6):1388–1400.
   PubMed Web of Science ®Google Scholar
• Hjertholm P, Fenger-Gron M, Vestergaard M, et al. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study. Int J Cancer. 2015;136(2):435–442.
   PubMed Web of Science ®Google Scholar
• NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic Countries, Version 8.0 (20.12.2017) [Internet]. Copenhagen (Denmark): Danish Cancer Society; 2017 [cited 2018 May 3]. Available from: http://www.ancr.nu
   Google Scholar
• Outzen M, Brasso K, Martinussen N, et al. Prostate cancer in Denmark 1978-2009–trends in incidence and mortality. Acta Oncol. 2013;52(4):831–836.
   PubMed Web of Science ®Google Scholar
• Klemann N, Roder MA, Helgstrand JT, et al. Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study. Lancet Oncol. 2017;18(2):221–229.
   PubMed Web of Science ®Google Scholar
• Lund Nilsen TI, Johnsen R, Vatten LJ. Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer. 2000;82(7):1358–1363.
   PubMed Web of Science ®Google Scholar
• Marsa K, Johnsen NF, Bidstrup PE, et al. Social inequality and incidence of and survival from male genital cancer in a population-based study in Denmark, 1994-2003. Eur J Cancer. 2008;44(14):2018–2029.
   PubMed Web of Science ®Google Scholar
• Berglund A, Garmo H, Robinson D, et al. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer. Eur J Cancer. 2012;48(1):75–84.
   PubMed Web of Science ®Google Scholar
• Klein J, von Dem Knesebeck O. Socioeconomic inequalities in prostate cancer survival: A review of the evidence and explanatory factors. Soc Sci Med. 2015;142:9–18.
   PubMed Web of Science ®Google Scholar
• Kilpelainen TP, Talala K, Raitanen J, et al. Prostate cancer and socioeconomic status in the Finnish randomized study of screening for prostate cancer. Am J Epidemiol. 2016;184(10):720–731.
   PubMed Web of Science ®Google Scholar
• Karlsen RV, Larsen SB, Christensen J, et al. PSA testing without clinical indication for prostate cancer in relation to socio-demographic and clinical characteristics in the Danish Diet, Cancer and Health Study. Acta Oncol. 2013;52(8):1609–1614.
   PubMed Web of Science ®Google Scholar
• Nordstrom T, Bratt O, Ortegren J, et al. A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies. Scand J Urol. 2016;50(2):104–109.
   PubMed Web of Science ®Google Scholar
• Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384(9959):2027–2035.
   PubMed Web of Science ®Google Scholar
• Aarts MJ, Koldewijn EL, Poortmans PM, et al. The impact of socioeconomic status on prostate cancer treatment and survival in the southern Netherlands. Urology. 2013;81(3):593–599.
   PubMed Web of Science ®Google Scholar
• Dalton SO, Olsen MH, Johansen C, et al. Socioeconomic inequality in cancer survival - changes over time. A population-based study, Denmark, 1987-2013. Acta Oncol. 2019;11:1–8.
   Google Scholar
• Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7):42–45.
   PubMed Web of Science ®Google Scholar
• Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(7):22–25.
   PubMed Web of Science ®Google Scholar
• Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39(7):91–94.
   PubMed Web of Science ®Google Scholar
• Pallesen PB, Tverborgvik T, Rasmussen HB, et al. Data on education: from population statistics to epidemiological research. Scand J Public Health. 2010;38(2):177–183.
   PubMed Web of Science ®Google Scholar
• Galobardes B, Shaw M, Lawlor DA, et al. Indicators of socioeconomic position (part 1). J Epidemiol Commun Health. 2006;60(1):7–12.
   PubMed Web of Science ®Google Scholar
• Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39(7):103–105.
   PubMedGoogle Scholar
• Petersson F, Baadsgaard M, Thygesen LC. Danish registers on personal labour market affiliation. Scand J Public Health. 2011;39(7):95–98.
   PubMedGoogle Scholar
• Dalton SO, Schuz J, Engholm G, et al. Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994-2003: summary of findings. Eur J Cancer. 2008;44(14):2074–2085.
   PubMed Web of Science ®Google Scholar
• Larsen SB, Brasso K, Christensen J, et al. Socioeconomic position and mortality among patients with prostate cancer: influence of mediating factors. Acta Oncol. 2017;56(4):563–568.
   PubMed Web of Science ®Google Scholar
• Larsen SB, Kroman N, Ibfelt EH, et al. Influence of metabolic indicators, smoking, alcohol and socioeconomic position on mortality after breast cancer. Acta Oncol. 2015;54(5):780–788.
   PubMed Web of Science ®Google Scholar
• Nijs HG, Essink-Bot ML, DeKoning HJ, et al. Why do men refuse or attend population-based screening for prostate cancer? J Public Health Med. 2000;22(3):312–316.
   PubMedGoogle Scholar
• Gorday W, Sadrzadeh H, de Koning L, et al. Association of sociodemographic factors and prostate-specific antigen (PSA) testing. Clin Biochem. 2014;47(16–17):164–169.
   PubMed Web of Science ®Google Scholar
• Prajsner A, Chudek J, Szybalska A, et al. Socioeconomic determinants of prostate-specific antigen testing and estimation of the prevalence of undiagnosed prostate cancer in an elderly Polish population based on the PolSenior study. Arch Med Sci. 2016;12(5):1028–1035.
   PubMed Web of Science ®Google Scholar
• Bowen DJ, Hannon PA, Harris JR, et al. Prostate cancer screening and informed decision-making: provider and patient perspectives. Prostate Cancer Prostatic Dis. 2011;14(2):155–161.
   PubMed Web of Science ®Google Scholar
• Ross LE, Coates RJ, Breen N, et al. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med. 2004;38(6):732–744.
   PubMed Web of Science ®Google Scholar
• Kay L, Stigsby B, Brasso K, et al. Lower urinary tract symptoms-a population survey using the Danish Prostatic Symptom Score (DAN-PSS) questionnaire. Scand J Urol Nephrol. 1999;33(2):94–99.
   PubMedGoogle Scholar
• Fowke JH, Murff HJ, Signorello LB, et al. Race and socioeconomic status are independently associated with benign prostatic hyperplasia. J Urol. 2008;180(5):2091–2096.
   PubMed Web of Science ®Google Scholar